Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome

被引：0
|
作者：
Zik, Chad [1 ]
Alan, Sheinei [1 ]
Ershler, William B. [1 ]
机构：
[1] Inova Schar Canc Inst, Adult Sickle Cell Ctr, Fairfax, VA USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170745
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11157 / 11158
页数：2
相关论文
共 50 条
  • [21] Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease
    Griessenauer, Christoph J.
    Lebensburger, Jeffrey D.
    Chua, Michelle H.
    Fisher, Winfield S., III
    Hilliard, Lee
    Bemrich-Stolz, Christina J.
    Howard, Thomas H.
    Johnston, James M.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2015, 16 (01) : 64 - 73
  • [22] Neurologic Complications of Sickle Cell Disease
    Shama Farooq
    Fernando D. Testai
    Current Neurology and Neuroscience Reports, 2019, 19
  • [23] Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome
    Rallo, Michael S.
    Akel, Omar
    Kalakoti, Piyush
    Sun, Hai
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (10):
  • [24] SURGICAL REVASCULARIZATION REDUCES STROKE RISK IN SICKLE CELL DISEASE AND MOYAMOYA SYNDROME
    Aldana, Philipp
    Hanel, Ricardo
    Piatt, Joseph
    Han, Sabrina
    Schultz, Corinna
    Gauger, Cynthia
    Bansal, Manisha
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [25] Moyamoya syndrome associated with sickle cell disease - Outcome following surgical revascularization
    Smith, Edward R.
    McClain, Craig D.
    Scott, R. Michael
    JOURNAL OF NEUROSURGERY, 2007, 106 (03) : A251 - A252
  • [26] A NOVEL IMAGING MODALITY FOR MANAGEMENT OF SICKLE CELL DISEASE PATIENTS WITH MOYAMOYA SYNDROME
    Khorasani, Leila
    Peddinti, Radhika
    Cunningham, John M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (12) : E59 - E59
  • [27] Anesthesia for cerebral revascularization for adult moyamoya syndrome associated with sickle cell disease
    Chong, Chin Ted
    Manninen, Pirjo H.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (12) : 1709 - 1712
  • [28] CANDIDA TROPICALIS FUNGEMIA IN AN ADOLESCENT PATIENT WITH SICKLE CELL DISEASE ON CRIZANLIZUMAB
    MacMath, D.
    Raymond, L.
    Rider, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S127 - S127
  • [29] Crizanlizumab in vaso-occlusive crisis caused by sickle cell disease
    Gardner, R., V
    DRUGS OF TODAY, 2020, 56 (11) : 705 - 714
  • [30] Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
    Kanter, Julie
    Brown, R. Clark
    Norris, Cynthia
    Nair, Santosh M.
    Kutlar, Abdullah
    Manwani, Deepa
    Shah, Nirmish
    Tanaka, Chiaki
    Bodla, Shankaranand
    Sanchez-Olle, Gessami
    Albers, Urs
    Liles, Darla
    BLOOD ADVANCES, 2023, 7 (06) : 943 - 952
12345